Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024 “Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report p ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2024
Anti-CD52 Antibody - Pipeline Insight, 2024 “Anti-CD52 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage o ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Acute Lymphoblastic L ... Read More
-
Allogenic iNKT Cell Therapy - Pipeline Insight, 2024
Allogenic iNKT Cell Therapy - Pipeline Insight, 2024 Allogenic iNKT Cell Therapy Overview ""Allogenic iNKT Cell Therapy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allogenic iNKT Cell Therapy ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024 “Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutic ... Read More
-
GPCR-Targeting Therapies - Pipeline Insight, 2024
GPCR-Targeting Therapies - Pipeline Insight, 2024 GPCR-Targeting Therapies Overview ""GPCR-Targeting Therapies Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the GPCR-Targeting Therapies market. A de ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024
CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma pipeline ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2024
Anti-CD3 Antibody - Pipeline Insight, 2024 “Anti-CD3 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of t ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2024
Anti-CD33 Antibody - Pipeline Insight, 2024 “Anti-CD33 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2024
Anti-CD28 Antibody - Pipeline Insight, 2024 “Anti-CD28 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage o ... Read More
-
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024 “Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Conve ... Read More
-
Apoptosis Inhibitor - Pipeline Insight, 2024
Apoptosis Inhibitor - Pipeline Insight, 2024 “Apoptosis Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Apoptosis Inhibitor development. The report provides detailed coverag ... Read More
-
GNE Myopathy - Pipeline Insight, 2024
GNE Myopathy - Pipeline Insight, 2024 GNE Myopathy Overview ""GNE Myopathy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the GNE Myopathy market. A detailed picture of the GNE Myopathy pipeline land ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated i ... Read More
-
Molecular Spectroscopy - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Molecular Spectroscopy - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Molecular Spectroscopy Market By Type (Mass Spectroscopy, Infrared Spectroscopy, UV-Visible Spectroscopy, NMR Spectroscopy, Raman Spectroscopy, And Others), Application (Pharmaceutical Industries, Food ... Read More
-
Biochips - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Biochips - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Biochips Market By Type (DNA Chips, Protein Chips, Lab-On-Chips, And Others), Application (Genomics And Proteomics, Drug Discovery, Diagnostics, IVD & POC, Gene Expression, And Others), End-User (Hospitals And Diagn ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by ... Read More
-
Nanomedicine - Market Insights, Competitive Landscape, and Market Forecast - 2028
Nanomedicine - Market Insights, Competitive Landscape, and Market Forecast - 2028 Nanomedicine Market By Molecule Type (Nanoparticle, Nanoshells, Nanotubes, And Nanodevices), Applications (Drug Delivery, Implants, Diagnostic Imaging, Biomaterials, And Others), Indication (Cardiovascular, Oncology, N ... Read More
-
Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2028
Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2028 Biopharmaceuticals Market By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Protein, Recombinant Protein, Recombinant Hormones, Synthetic Immunomodulators, And Others), Application (Onc ... Read More
-
Anti-CD38 antibody- Pipeline Insight, 2023
Anti-CD38 antibody- Pipeline Insight, 2023 DelveInsight’s, “Anti-CD38 antibody- Pipeline Insight, 2023” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More
-
CAR-T Therapy- Pipeline Insight, 2023
CAR-T Therapy- Pipeline Insight, 2023 DelveInsight’s, “CAR-T Therapy- Pipeline Insight, 2023” report provides comprehensive insights about 200+ companies and 252+ pipeline drugs in CAR-T Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produc ... Read More
-
mRNA-1010 Emerging Drug Insight and Market Forecast − 2032
mRNA-1010 Emerging Drug Insight and Market Forecast − 2032 “mRNA-1010 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about mRNA-1010 for seasonal influenza in the seven major markets. A detailed picture of the mRNA-1010 for seasonal influenza in the 7MM, i.e ... Read More
-
GLIOVAC Emerging Drug Insight and Market Forecast − 2032
GLIOVAC Emerging Drug Insight and Market Forecast − 2032 “GLIOVAC Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about GLIOVAC for glioblastoma multiforme (GBM) in the seven major markets. A detailed picture of the GLIOVAC for GBM in the 7MM, i.e., the Unite ... Read More
-
Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Cardiac Biomarkers Testing Market By Product Type (Instruments and Reagents & Kits), Biomarker Type (Troponin, Creatine Kinase-Mb, B-Type Natriuretic Peptide, Myoglobin, and Others]), Appli ... Read More
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Market Insight, Epidemiology And Market Forecast - 2032
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis is a heterogeneous group of rare autoimmune conditions. ANCA Associated Vasculitis includes three ma ... Read More
Research Assistance
